Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection

Silvia Nozza, Alba Bigoloni, Andrea Calcagno, Laura Galli, Angela Rosa Pignataro, Antonio D'Avolio, Alessia Carbone, Marco Ripa, Stefano Bonora, Adriano Lazzarin, Antonella Castagna

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numberdkt530
Pages (from-to)1436-1439
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Issue number5
Publication statusPublished - 2014


  • Multidrug resistance
  • Raltegravir andmaraviroc dosing
  • Simplification

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this